🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 10 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/09/2019 31,84 32,27 31,32 31,51 -1,04% 2,98% 851.100
05/09/2019 34,58 34,70 30,80 31,84 -7,01% 11,28% 2.393.500
04/09/2019 33,55 34,26 33,09 34,24 +3,04% 3,49% 1.550.300
03/09/2019 34,43 34,89 33,04 33,23 -2,75% 5,37% 1.285.000
30/08/2019 35,61 36,80 33,68 34,17 -1,98% 8,76% 1.650.100
29/08/2019 35,00 35,69 33,79 34,86 +1,46% 5,43% 1.307.900
28/08/2019 32,80 34,84 32,79 34,36 +4,37% 6,25% 1.351.000
27/08/2019 32,66 33,34 32,27 32,92 +2,17% 3,27% 1.562.800
26/08/2019 31,48 32,30 31,25 32,22 +4,34% 3,34% 1.884.000
23/08/2019 32,03 32,73 30,71 30,88 -3,86% 6,29% 1.163.800
22/08/2019 34,60 34,93 31,81 32,12 -6,90% 9,04% 1.787.700
21/08/2019 33,90 35,41 33,64 34,50 +2,31% 5,22% 1.501.400
20/08/2019 33,90 33,90 33,03 33,72 +0,00% 2,57% 1.513.900
19/08/2019 32,20 34,02 31,57 33,72 +8,11% 7,61% 1.714.900
16/08/2019 29,33 31,56 29,30 31,19 +6,89% 7,71% 1.525.700
15/08/2019 29,90 30,06 29,14 29,18 -2,01% 3,08% 598.600
14/08/2019 28,93 30,11 28,84 29,78 +0,51% 4,39% 1.006.300
13/08/2019 29,11 30,25 29,11 29,63 +1,26% 3,92% 815.900
12/08/2019 28,85 29,49 28,41 29,26 +0,72% 3,74% 811.400
09/08/2019 28,96 29,47 28,65 29,05 -0,31% 2,83% 731.000
08/08/2019 28,85 29,33 27,91 29,14 +1,36% 4,92% 873.600
07/08/2019 28,36 28,96 28,01 28,75 +0,88% 3,35% 991.000
06/08/2019 28,28 29,80 27,83 28,50 +4,63% 6,97% 2.083.200
05/08/2019 28,45 28,72 27,24 27,24 -6,46% 5,20% 1.701.900
02/08/2019 29,29 29,52 28,76 29,12 -1,39% 2,59% 756.000
01/08/2019 29,19 30,30 29,17 29,53 +1,62% 3,87% 1.110.900
31/07/2019 29,60 29,90 28,94 29,06 -1,66% 3,24% 840.000
30/07/2019 28,22 29,58 28,10 29,55 +3,07% 5,24% 939.700
29/07/2019 29,67 29,68 28,44 28,67 -2,88% 4,18% 1.079.100
26/07/2019 29,02 29,64 29,01 29,52 +2,54% 2,15% 1.383.600